Page 2 - Vaccine

IIL develops live-attenuated, needle-free intranasal Covid-19 vaccine

The contagion still killing 1,700 people every week across the world, says WHO

Bharat Biotech launches oral cholera vaccine after positive phase 3 trial

Bharat Biotech in a release said it plans to bridge a worldwide deficit of 40 million doses per year through Hillchol

WHO partners can start talks to buy mpox vaccines before approval

Earlier this month, the WHO asked vaccine manufacturers to submit information so it could accelerate its approval process, and grant an emergency licence by mid-September

AstraZeneca warns of shifting UK vaccine production to US: Report

An AztraZeneca spokesperson said there are no discussions in the US or India as the company is committed to pursuing the opportunity at Speke and are in constructive talks with the UK government

Expects positive news on indigenous Mpox vaccine within a year: Poonawalla

Mpox cases have been confirmed among children and adults in more than a dozen African countries, and a new form of the virus is spreading

How lack of coordination, funding issues turned mpox into a global crisis

The chain of delayed reactions to the crisis began during the last mpox emergency that ended in 2023

India's health system on alert as viral infection mpox scare grows

Hyderabad and New Delhi, which serve as popular destinations for students from Africa to pursue higher education, are also on alert after the news

WHO calls for surveillance, sharing of vaccines to combat mpox outbreak

Recently, Sweden confirmed the first case of mpox Clade I, a viral infection that spreads through close contact

Bavarian Nordic seeks EU's approval to extend mpox vaccine to adolescents

Mpox has been declared a global public health emergency by the World Health Organization, with children and adolescents being particularly vulnerable to the disease

Mpox vaccines maybe months away even as WHO, Africa CDC discuss emergency

Africa Centres for Disease Control and Prevention declared public health emergency of continental concern for first time ever, and today, a WHO-led panel meets to decide if it represents global threat

SC dismisses plea for centre-wise data of anti-diarrhoea vaccine trial

The Supreme Court on Tuesday dismissed a plea seeking centre-wise data of the clinical trial of anti-diarrhoea vaccine Rotavac, saying it cannot sit in appeal over the decision taken by an expert committee on the issue. Rotavirus vaccine, Rotavac, claims that it protects children from viruses, which are the leading cause of severe diarrhoea among them. A bench of justices B R Gavai and K V Viswanathan passed the order while hearing a plea seeking directions to the Centre and others to make public the "segregated data" on the results of third phase of clinical trial of Rotavac involving 6,799 infants. The plea had stated the trials were conducted at three centres at Delhi, Pune and Vellore to gauge the safety and efficacy of the vaccine. It had claimed that the data should have been examined by the National Technical Advisory Group on Immunization (NTAGI) in "public interest but such is the secrecy surrounding it, it has not been provided even to this apex body". During the hearing

Acquisition of BSV to aid future growth of Mankind Pharma: V-C Juneja

The acquisition of Bharat Serums and Vaccines would add a lot of value, aiding future growth of Mankind Pharma, according to Vice Chairman and Managing Director Rajeev Juneja. On July 25, Mankind had announced that it will fully acquire Bharat Serums and Vaccines (BSV) from Advent International for an enterprise value of around Rs 13,630 crore. "One thing should be very clear, this acquisition is not to really add some kind of revenue, but to add a lot of value, future growth, entry barrier, super specialty business in Mankind," Juneja said in an analyst call. Whatever the company is paying for BSV, it is very relevant as the company has "so much of value" with well established business, he said. The acquisition is in line with the company's strategy of buying high entry barrier businesses, he stated. The buyout will solidify Mankind's position with complementary drug portfolio and extensive reach to target rapidly growing highly under-penetrated markets, especially in fertility,

Vaccine developer Sinergium to share bird flu vaccine data globally: WHO

Until now, the WHO has assisted partners but this is the first time one of them with a vaccine in development has volunteered to share it with others

Shutting down vaccine PSUs will erode capabilities further, says Congress

The Congress on Friday hit out at the government over the Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) reportedly facing a "grim future", and said shutting down vaccine PSUs will only erode the country's capabilities further. Congress general secretary in-charge communications Jairam Ramesh shared on X a media report which claimed that the BIBCOL factory in Uttar Pradesh's Bulandshahr, that was at the forefront of India's fight against polio before, hasn't produced a single vaccine since December 2022. "Bharat Immunologicals and Biologicals Corporation (BIBCOL) was set up in the late 1980s, at the personal initiative of Prime Minister Rajiv Gandhi, to make India self-sufficient in the production of oral polio vaccines. It was my good fortune to have been associated with its establishment at Bulandshahr in UP as part of the technology mission on immunisation," Ramesh said in a post on X. But BIBCOL now faces a "grim future in the era of the non-biological PM", h

Mankind Pharma acquires Bharat Serums and Vaccines for Rs 13,600 crore

More than 2,500 BSV employees will be joining Mankind

India may have dengue vaccine by 2026; Takeda initiates clinical trials

Takeda follows a dual pricing strategy in both private and public markets, and as such, prices in the private market are higher in Europe than in Asian markets

Decoded: Who are zero-dose children and what does the Unicef report mean?

Acc to the latest World Health Organisation (WHO) and Unicef immunisation report, India follows Nigeria in having the highest number of unvaccinated children, with 1.6 million zero-dose kids in 2023

Culling, surveillance but no vaccine strategy to fight 'bird flu'

Experts said as India falls on the one of main pathways that migratory birds take to move between continents, its water bodies are always prone to the spread of influenza from birds

Pan India rollout of U-WIN to track routine vaccinations likely by Aug end

The U-WIN portal, a replication of the Covid-19 vaccine management system Co-WIN, is set for a pan-India launch likely by the end of August, aiming to maintain an electronic registry of routine immunisations, official sources said. Currently, U-WIN is in pilot mode across all states and Union Territories, except for West Bengal, which is yet to start uploading data, the sources told PTI, adding that it is still under consideration in the state. The U-WIN platform captures every vaccination event for pregnant women and children under the Universal Immunization Programme (UIP). Minister of Finance Nirmala Sitharaman had announced in the interim Budget for 2024-2025 that U-WIN, along with intensified efforts under Mission Indradhanush, will be rolled out nationwide for managing immunisation. "The U-WIN will ensure timely administration of vaccine doses by digitally recording every vaccination event under the Universal Immunisation Programme among all pregnant women and children aged 0

As Covid-19 ticks up, US advisers recommend a fall vaccination campaign

With fresh COVID-19 cases bubbling up in some parts of the country, health officials are setting course for a fall vaccination campaign. An influential government advisory panel on Thursday recommended new shots for all Americans this fall. The director of the Centers for Disease Control and Prevention must endorse the recommendation. Officials acknowledged the need for vaccinations is not as dire as it was only a few years ago. Most Americans have some degree of immunity from being infected, from past vaccinations or both. COVID-19 deaths and hospitalizations last month were at about their lowest point since the pandemic first hit the United States in 2020. But immunity wanes, new coronavirus variants keep emerging and there are still hundreds of COVID-19-associated deaths and thousands of hospitalizations reported each week. What's more, health officials have reported upticks this month in COVID-19-associated emergency room visits and hospitalizations, and a pronounced increase i